Track 18: Blood Cancer – Advancing Research, Diagnosis, and Treatment at the 13th International Cancer and Medical Oncology Conference and Exhibition
Blood cancer remains one of the most complex and impactful areas of oncology, affecting the production and function of blood cells and posing significant challenges in diagnosis, treatment, and long-term patient care. Track 18: Blood Cancer at the 13th International Cancer and Medical Oncology Conference and Exhibition, taking place on February 1–2, 2027 at Novotel Al Barsha, Dubai, UAE, is designed to bring together hematologists, oncologists, researchers, clinicians, academicians, and healthcare innovators to discuss the latest breakthroughs in hematologic malignancies and precision oncology. The conference offers participants a global platform for scientific exchange, networking, and professional development, along with eligibility for 30 CME/CPD Credits for qualified attendees.
About Track 18: Blood Cancer
Track 18 focuses on cancers that affect the blood, bone marrow, and lymphatic system, including:
This scientific track highlights cutting-edge developments in diagnosis, molecular pathology, targeted therapies, immunotherapies, clinical trials, and patient-centered treatment approaches aimed at improving survival and quality of life for blood cancer patients.
Why Blood Cancer is a Critical Oncology Topic
Blood cancers account for a major global burden of cancer-related morbidity and mortality. Unlike solid tumors, blood cancers often involve systemic disease processes requiring multidisciplinary care, advanced diagnostics, and individualized therapeutic strategies. Recent innovations such as targeted therapies, genomic profiling, stem cell transplantation, and CAR-T cell therapies have transformed treatment outcomes, making blood cancer research one of the fastest-evolving fields in oncology. This track provides a platform for experts to explore these transformative advancements and share evidence-based clinical insights.
Key Benefits of Attending Track 18: Blood Cancer
Gain insights into the latest blood cancer therapies and treatment protocols
Learn about advances in leukemia, lymphoma, and myeloma management
Explore stem cell transplantation and cellular therapy innovations
Understand molecular diagnostics and genomic medicine in hematologic oncology
Connect with international hematologists and oncology specialists
Present research through oral and poster sessions
Discover clinical trial opportunities and translational research developments
Build global academic and professional collaborations
Enhance clinical knowledge and patient management strategies
Earn 30 CME/CPD Credits for professional development and accreditation purposes
Scientific Highlights of Blood Cancer Track
Leukemia Research
Discussion on acute and chronic leukemias, molecular markers, personalized therapy, and emerging treatment protocols.
Lymphoma and Immunotherapy
Advances in Hodgkin and Non-Hodgkin lymphoma management, monoclonal antibodies, checkpoint inhibitors, and immunotherapy.
Multiple Myeloma
Novel therapies, relapse prevention, bone marrow microenvironment research, and precision medicine strategies.
Stem Cell Transplantation
Current developments in autologous and allogeneic transplantation and post-transplant management.
CAR-T Cell and Cellular Therapies
Exploration of next-generation engineered cell therapies transforming blood cancer treatment.
Molecular Diagnostics
Biomarkers, genomic profiling, liquid biopsy, and personalized medicine in hematologic malignancies.
Conference Summary
The 13th International Cancer and Medical Oncology Conference and Exhibition is a premier international platform that gathers oncologists, clinicians, researchers, policymakers, industry experts, and academicians to discuss emerging trends and breakthroughs in cancer science. The conference includes 80+ scientific sessions, keynote lectures, poster presentations, networking forums, exhibitions, and multidisciplinary discussions across a broad range of oncology specialties. Participants can engage in scientific collaboration while earning globally recognized 30 CME or 30 CPD credits through eligible participation.
Venue Information
The conference will be hosted at Novotel Al Barsha, a modern 4-star conference venue located on Sheikh Zayed Road in Dubai. The hotel offers:
Dubai’s strategic global location makes it an ideal destination for international scientific conferences and professional networking.
Additional Conference Information
Conference Name: 13th International Cancer and Medical Oncology Conference and Exhibition
Opportunities: Speaker, Delegate, Poster Presenter, Exhibitor, Sponsor
Conclusion
Track 18: Blood Cancer offers an exceptional scientific platform to explore the future of hematologic oncology, from molecular diagnostics to cellular therapies and precision medicine. Whether you are a clinician, hematologist, researcher, student, or healthcare professional, this track provides invaluable opportunities for learning, collaboration, research presentation, and professional advancement. Join leading experts in Dubai to contribute to the advancement of blood cancer care and innovation in global oncology.
Important Links
https://cancer.utilitarianconferences.com/
https://cancer.utilitarianconferences.com/registration
https://cancer.utilitarianconferences.com/submit-abstract
.jpg)
Comments
Post a Comment